These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19931469)

  • 1. Infectious prion protein in the filtrate even after 15 nm filtration.
    Yunoki M; Tanaka H; Urayama T; Kanai Y; Nishida A; Yoshikawa M; Ohkubo Y; Kawabata Y; Hagiwara K; Ikuta K
    Biologicals; 2010 Mar; 38(2):311-3. PubMed ID: 19931469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of prion reduction filters in decreasing infectivity of ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" human blood and red blood cells.
    Cardone F; Sowemimo-Coker S; Abdel-Haq H; Sbriccoli M; Graziano S; Valanzano A; Berardi VA; Galeno R; Puopolo M; Pocchiari M
    Transfusion; 2014 Apr; 54(4):990-5. PubMed ID: 23915063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion removal by nanofiltration under different experimental conditions.
    Yunoki M; Tanaka H; Urayama T; Hattori S; Ohtani M; Ohkubo Y; Kawabata Y; Miyatake Y; Nanjo A; Iwao E; Morita M; Wilson E; MacLean C; Ikuta K
    Biologicals; 2008 Jan; 36(1):27-36. PubMed ID: 17890100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of exogenous prion infectivity in leukoreduced red blood cells unit by a specific filter designed for human transfusion.
    Lescoutra-Etchegaray N; Sumian C; Culeux A; Durand V; Gurgel PV; Deslys JP; Comoy EE
    Transfusion; 2014 Apr; 54(4):1037-45. PubMed ID: 24117735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
    Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
    Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions.
    Cardone F; Simoneau S; Arzel A; Puopolo M; Berardi VA; Abdel-Haq H; Galeno R; De Pascalis A; Sbriccoli M; Graziano S; Valanzano A; Porte P; Diringer H; Brown P; Flan B; Pocchiari M
    Transfusion; 2012 May; 52(5):953-62. PubMed ID: 22082124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
    Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
    Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of TSE agents by depth or membrane filtration from plasma products.
    Roberts PL; Evans D; Harris L
    Biologicals; 2010 Jan; 38(1):158-61. PubMed ID: 19854662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies.
    Cai K; Gröner A; Dichtelmüller HO; Fabbrizzi F; Flechsig E; Gajardo R; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Lee DC; Moscardini M; Pölsler G; Roth NJ
    Transfusion; 2013 Sep; 53(9):1894-905. PubMed ID: 23252676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disinfection of gas-permeable contact lenses against prions].
    Comoy E; Bonnevalle C; Métais A; Auvré F; Letessier F; Lamoury F; Spittler J; Dormont D; Deslys JP
    J Fr Ophtalmol; 2003 Mar; 26(3):233-9. PubMed ID: 12746598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment.
    Lehmann S; Pastore M; Rogez-Kreuz C; Richard M; Belondrade M; Rauwel G; Durand F; Yousfi R; Criquelion J; Clayette P; Perret-Liaudet A
    J Hosp Infect; 2009 Aug; 72(4):342-50. PubMed ID: 19541387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond leukodepletion: removing infectious prions by filtration.
    Eglin RP; Murphy WG
    Transfusion; 2005 Dec; 45(12):1836-8. PubMed ID: 16371035
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of depth filtration to remove prion challenge from an immune globulin preparation.
    Van Holten RW; Autenrieth SM
    Vox Sang; 2003 Jul; 85(1):20-4. PubMed ID: 12823726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of prion infectivity by affinity ligand chromatography during OctaplasLG® manufacturing--results from animal bioassay studies.
    Heger A; Bailey A; Neisser-Svae A; Ertl M; Römisch J; Svae TE
    Vox Sang; 2012 May; 102(4):294-301. PubMed ID: 22070802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of prion removal/inactivation from chromatographic gel.
    Thyer J; Unal A; Hartel G; Middleton D; Bingham J; Braun M; Uren E; Maher D
    Vox Sang; 2006 Nov; 91(4):301-8. PubMed ID: 17105605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen safety of human C1 esterase inhibitor concentrate.
    Gröner A; Nowak T; Schäfer W
    Transfusion; 2012 Oct; 52(10):2104-12. PubMed ID: 22413956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.